53Biologics is adding new lyophilisation equipment and an isolator to its facilities, completing its fill and finish capabilities so the company is fully end to end. That means the small batches first clinical trials need can stay under one roof.
On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Javier Santos, Business Developer at 53Biologics, about the company's new in-house lyophilisation and what it means for customers' clinical programmes.
In this episode, Javier covers:
(00:33) 53Biologics' new lyophilisation equipment and isolator, which complete its fill and finish capabilities and make the company end to end, in line with its philosophy.
(01:05) Why the small batches needed for first clinical trials are so hard to place with outside fill and finish suppliers, and how bringing the work in house removes that bottleneck, especially in phase one.
(02:14) How keeping every step with one partner makes customers' projects quicker and more efficient, with no extra contracts and no separate providers' timelines to manage.
(03:13) What his conversations at CPHI have confirmed: clients across many projects are asking for the same small batches, so the capability needs to be in place.
Watch the full episode to hear why Javier sees having everything under one roof as the answer to the small-batch bottleneck.
Register your interest for CPHI Frankfurt 2027 here: https://www.cphi.com/europe/register-attend/?utm_source=partner&utm_medium=referral&utm_campaign=hln27cpw-cl-arto
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent/
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent
TikTok: https://www.tiktok.com/@artotalent
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com/
Youtube: https://www.youtube.com/@artotalent
Javier Santos
LinkedIn: https://www.linkedin.com/in/javier-santos-aberturas-96b7a45a/
Ruby Collier
LinkedIn: https://www.linkedin.com/in/ruby-collier/
Timestamps:
00:00 Introduction
00:52 Why small clinical batches need in-house fill and finish
01:58 Simpler projects, everything in one place
02:58 What CPHI conversations have confirmed
03:52 Closing thoughts
#Newsbeat #ARTOTalent #CPHI #CPHIMilan #FillAndFinish #Lyophilisation #Biologics #CDMO
","author_name":"ARTO Talent"}